ICTR News Archive
January 2024: Danya Qato, UMB ICTR 2019 KL2 Awardee, Receives Diversity Recognition Award ▾
March 2023: UMB ICTR and UMMS Launch TriNetX ▾
We are excited to announce that the University of Maryland Medical System (UMMS) and the University of Maryland, Baltimore's (UMB) Institute for Clinical & Translational Research (ICTR) have jointly founded a new Clinical Research Data Sub-core to centralize and streamline the provision of clinical and translational data. Included in this partnership is the launching of TriNetX, a powerful querying tool that is populated with UMMS patient data that has been cleaned, curated, and more fully mapped to improve data quality and analysis. Read more here.
February 2023: Congratulations ICTR 2023 Pilot Grant Awardees! ▾
The UMB ICTR Announcing Recipients of the 2023 Pilot Grant Rounds! From a pool of 25 applications, the ICTR awarded 9 ATIP Grants, 2 Community Engaged Research (CEnR) Grants, and 4 Special Nephrotic Syndrome Research Program (NSRP) Grants...
November 2022: UMB ICTR Announces the CEnR Voucher Award Inaugural Round ▾
The UMB ICTR Announces the ICTR 2022 Inaugural Community Engaged Research (CEnR) Voucher Award Opportunity. The CEnR Voucher Award is specifically for developing a successful and sustainable community partnership(s) in the Maryland and/or District of Columbia (DC) area. The purpose of this award is to prepare for a future, competitive ICTR CEnR proposal, or for other extramural CEnR-type grant applications.
July 2022: Congratulations to the Awardees of the ICTR Inaugural CEnR Pilot Grant Round! ▾
The UMB ICTR Announces the ICTR 2022 Inaugural Community Engaged Research (CEnR) Pilot Grant Awardees. The CEnR pilot grant provides starter funds for projects specifically focused on innovative approaches to addressing health problems through community-engaged implementation. Read more here.
The UMB ICTR Announces a Special Call for Applications for Two Funding Opportunities Focused on the Physiology, Pathophysiology and/or Treatment of Nephrotic Syndrome: A Two-Year Pilot Grant Award and a KL2 Mentored Career Development Award. These one-time funding opportunities are supported by a Mallinckrodt Pharmaceuticals settlement managed by UMB ICTR. Read more here.
September 2021: NIH’s All of Us Research Program Releases New COVID-19 Data. UMB has access. ▾
The UMB HSHSL can help UMB faculty with accessing this data. Email JP Courneya jpcourneya@hshsl.umaryland.edu or Amy Yarnell ayarnell@hshsl.umaryland.edu
November 9, 2020: UMB ICTR KL2 Scholars Forging Ahead During Healthcare Crises ▾
While the nation is undergoing unprecedent pandemic and opioid crises, Internal KL2 Scholars from UMB’s Institute of Clinical Translational Research (ICTR) are thriving and meeting these healthcare challenges. Read more...
October 8, 2020: UMB PATIENTS Program Hosts First Ever Community Research Jam ▾
The PATIENTS Program at the University of Maryland School of Pharmacy hosted its first-ever Community Research Jam on Sept. 10. Organized in collaboration with the University of Maryland, Baltimore (UMB) Institute for Clinical & Translational Research’s (ICTR) Community and Collaboration Core, the event aimed to demonstrate the value of early engagement in research.
August 26, 2020: COVID-19 Not Stopping UMB ICTR 2019 Scholars From Sharing Their Experiences
▾
The COVID-19 pandemic is not stopping the UMB ICTR 2019 TL1 Pre- and Postdoctoral Scholars, and KL2 Career Development Scholars from reaching out from their homes to share with us the rich and rewarding experiences and opportunities they have had!
May 9, 2019: UMB President Jay A. Perman, MD, Announces CTSA in 2019 UMB SOTU Address ▾